SOURCE: Cutting Edge Information

Cutting Edge Information

February 18, 2016 10:56 ET

Sixty Percent of Surveyed Top 10 Companies Leverage Acquisitions to Develop and Commercialize Products, According to Cutting Edge Information

RESEARCH TRIANGLE PARK, NC --(Marketwired - February 18, 2016) - Because the development and commercialization of medical devices consumes a wealth of resources, many device manufacturers look to partnerships and acquisitions to move products from the laboratory to market. Acquisitions help manufacturers gain technology, intellectual property or round out their own product portfolios, according to primary intelligence provider Cutting Edge Information.

Medical Device Development: Benchmarking U.S. Early Stage Product Management and Promotion serves as a guide to medical device manufacturers that are undertaking new product planning strategies and early commercialization initiatives for US-based launches. Sixty percent of Top 10 companies use acquisitions to their advantage during product development and commercialization: surveyed Top 50 and small companies; seven and 11 percent, respectively. 

Of the Top 10 companies that reported acquisitions, half gained whole companies or technology. Many companies, especially larger firms, look to acquisitions to round out their own product portfolios.

"Some companies look externally to fill gaps in product portfolios, but they must take care to conduct due diligence before acquiring medical devices," said Victoria Cavicchi, senior research analyst at Cutting Edge Information. "If a problem surfaces after your company has obtained a product, it will be your responsibility to fix the issue before the FDA gets involved."

Medical Device Development: Benchmarking U.S. Early Stage Product Management and Promotion presents unique approaches to medical device development and commercialization and examines the human and financial resources needed to support these processes. This report's market intelligence also affirms that appropriately resourcing commercialization boards enables teams to better support product launches.

The report, available at, examines new product planning for established and emerging medical device firms launching brands in the U.S. market. Report highlights include:

  • Detailed profiles of 11 medical device manufacturers and their products, including budget and staffing resource levels required to support development and commercialization, development timelines and commercial competition levels
  • Benchmarks on surveyed companies' expected commercial success, including projected market share and competition levels in the U.S.
  • Exploration of commercial board implementation and staffing across product development stages
  • Executive insight on determining a product's best-fit regulatory pathway as well as guidelines for determining the viability of partnering to support product development

For more information about medical device commercialization in the U.S., please visit

Image Available:

Contact Information